TRIPODI, ARMANDO
TRIPODI, ARMANDO
Dipartimento di Scienze Cliniche e di Comunità
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defects
2024 A. Lecchi, S. La Marca, L. Padovan, M. Boscarino, F. Peyvandi, A. Tripodi
Testosterone therapy does not affect coagulation in male hypogonadism: a longitudinal study based on thrombin generation
2024 V. Lanzi, R. Indirli, A. Tripodi, M. Clerici, M. Bonomi, B. Cangiano, I. Petria, M. Arosio, G. Mantovani, E. Ferrante
Comprehensive investigation of platelet function in patients with cirrhosis
2024 A. Lecchi, G. Tosetti, C. Ghali, S. La Marca, M. Clerici, L. Padovan, E.A. Femia, M. Primignani, V. La Mura, P. Lampertico, F. Peyvandi, A. Tripodi
COVID-19. Comparison of D-dimer levels measured with 3 commercial platforms
2023 E. Scalambrino, M. Clerici, S. Scardo, M. Capecchi, C. Della Noce, S. Testa, F. Peyvandi, A. Tripodi
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
2023 M. Capecchi, P. De Leo, M. Abbattista, I. Mancini, P. Agosti, M. Biganzoli, C. Suffritti, B. Ferrari, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, A. Tripodi, A. Artoni, R. Gualtierotti, F. Peyvandi
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
2023 A. Tripodi, E. Scalambrino, M. Clerici, F. Peyvandi
Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations
2023 A. Tripodi, E. Scalambrino, M. Clerici, V. Chantarangkul, F. Peyvandi
The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants
2023 A. Tripodi, V. Chantarangkul, D. Poli, S. Testa, P. Bucciarelli, F. Peyvandi
Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count
2023 M. Scavone, G. Podda, A. Tripodi, M.N. Cattaneo
Hemophilia patients: are they naturally anticoagulated?
2023 A. Tripodi, P.M. Mannucci, F. Peyvandi
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges
2022 V. LA MURA, N. Bitto, A. Tripodi
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
2022 L. Valenti, A. Tripodi, V. La Mura, S. Pelusi, C. Bianco, E. Scalambrino, S. Margarita, F. Malvestiti, L. Ronzoni, M. Clerici, R. D'Ambrosio, M. Fraquelli, R. Carpani, D. Prati, F. Peyvandi
Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia
2022 V. LA MURA, N. Gagliano, F. Arnaboldi, P.M. Sartori, P. Procacci, L. Denti, E. Liguori, N. Bitto, G. Ristagno, R. Latini, D.E. Dondossola, F. Salerno, A. Tripodi, M. Colombo, F. Payvandi
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
2022 A. Tripodi, R. Lombardi, M. Primignani, V. La Mura, F. Peyvandi, A.L. Fracanzani
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian association for the study of the liver (AISF)
2022 G. Tosetti, E. Farina, R. Caccia, A. Sorge, A. Berzuini, L. Valenti, D. Prati, A. Tripodi, P. Lampertico, M. Primignani
Hemostatic alterations in COVID-19
2021 F. Peyvandi, A. Artoni, C. Novembrino, S. Aliberti, M. Panigada, M. Boscarino, R. Gualtierotti, F. Rossi, R. Palla, I. Martinelli, G. Grasselli, F. Blasi, A. Tripodi
Procoagulant imbalance in Klinefelter syndrome assessed by thrombin generation assay and whole blood thromboelastometry
2021 R. Indirli, E. Ferrante, E. Scalambrino, E. Profka, M. Clerici, T. Lettera, A.L. Serban, W. Vena, A. Pizzocaro, M. Bonomi, B. Cangiano, G. Carosi, G. Mazziotti, L. Persani, A. Lania, M. Arosio, F. Peyvandi, G. Mantovani, A. Tripodi
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
2021 S. Bonato, A. Artoni, A. Lecchi, G. Schwarz, S. La Marca, L. Padovan, M. Clerici, C. Guadino, G.P. Comi, A. Tripodi, F. Peyvandi
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels
2021 M. Capecchi, E. Scalambrino, S. Griffini, E. Grovetti, M. Clerici, G. Merati, V. Chantarangkul, M. Cugno, F. Peyvandi, A. Tripodi
Anti-TNF-α treatment reduces the baseline procoagulant imbalance of patients with inflammatory bowel diseases
2021 A. Tripodi, L. Spina, L.F. Pisani, L. Padovan, F. Cavallaro, V. Chantarangkul, C. Valsecchi, F. Peyvandi, M. Vecchi